AstraZeneca Newsroom

AstraZeneca: Strong Oncology Pipeline Fuels Growth and Outperformance – Buy Rating Endorsed

TipRanksSep 18 17:30

UBS Sticks to Its Sell Rating for AstraZeneca (AZN)

TipRanksSep 16 14:29

AstraZeneca Target Cut to 10500p From 11000p by Deutsche Bank

Dow JonesSep 13 14:31

Kepler Capital Sticks to Their Hold Rating for AstraZeneca (AZN)

TipRanksSep 12 09:48

BMO Capital Maintains AstraZeneca(AZN.US) With Buy Rating, Maintains Target Price $89

Futu NewsSep 12 03:31

AstraZeneca Raised to Buy From Hold by Erste Group

Dow JonesSep 12 02:02

AstraZeneca Analyst Ratings

BenzingaSep 12 01:52

Erste Group Upgrades AstraZeneca(AZN.US) to Buy Rating

Futu NewsSep 11 19:33

AstraZeneca Buy Rating Affirmed: Anticipated FDA Approval of Dato and Long-Term Growth Potential

TipRanksSep 11 15:27

AstraZeneca's Promising NSCLC Treatment: A Buy Rating Amidst Breakthrough Developments

TipRanksSep 10 15:59

AstraZeneca (AZN) Receives a Buy From Barclays

TipRanksSep 10 14:25

BofA Securities Maintains AstraZeneca(AZN.US) With Buy Rating, Announces Target Price $91.7

Futu NewsSep 10 10:31

AstraZeneca's Promising Biomarker Data and Phase III Trials: Buy Rating Affirmed

TipRanksSep 9 17:57

Citi Sticks to Its Buy Rating for AstraZeneca (AZN)

TipRanksSep 9 13:48

AstraZeneca: A Buy Rating on Anticipated Growth and Innovation Catalysts

TipRanksSep 5 12:57

Berenberg Bank Maintains AstraZeneca(AZN.US) With Buy Rating, Raises Target Price to $99

Futu NewsSep 3 14:32

Berenberg Bank Remains a Buy on AstraZeneca (AZN)

TipRanksSep 3 13:47

Berenberg Bank Reaffirms Their Buy Rating on AstraZeneca (AZN)

TipRanksSep 3 13:47

The latest pharmaceutical industry rating by S&P reveals that Johnson & Johnson (JNJ.US) and Roche (RHHBY.US) are ranked at the top for superior financial and innovative abilities.

Zhitong FinanceAug 19 11:30

AstraZeneca (AZN) Receives a Sell From UBS

TipRanksAug 13 21:09